The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, Validity, and Factor Structure of the Persian Version

被引:29
作者
Mohammadi, Khadijeh [1 ]
Rahnama, Parvin [1 ]
Montazeri, Ali [2 ]
Foley, Frederick W. [3 ]
机构
[1] Shahed Univ, Fac Nursing & Midwifery, Dept Midwifery, Tehran, Iran
[2] Acad Ctr Educ Culture & Res, Iranian Inst Hlth Sci Res, Hlth Metr Res Ctr, Mental Hlth Res Grp, Tehran, Iran
[3] Yeshiva Univ, Ferkauf Grad Sch Psychol, New York, NY 10033 USA
关键词
Multiple Sclerosis; Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19); Reliability; Validity; Neurological Disease; Sexual Function; DYSFUNCTION; DEPRESSION; PREVALENCE; IRAN;
D O I
10.1111/jsm.12531
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 (MSISQ-19) was designed to assess the perceived influence of multiple sclerosis (MS) symptoms on sexual activity and satisfaction. Aims This study aimed to translate and validate the MSISQ-19 in women with MS in Iran. Methods The translation of the original questionnaire was carried out in accordance with a standard forward-backward procedure. Then, a sample of 226 married women with MS completed the questionnaire. Reliability was estimated using Cronbach's alpha coefficient. Concurrent validity was assessed by comparison with the Female Sexual Function Index (FSFI), the Expanded Disability Status Scale (EDSS), and the Beck Depression Inventory-II (BDI-II). The factor structure of the questionnaire was extracted by performing exploratory factor analyses. All patients underwent a full neurologic examination. Main Outcome Measures MSISQ-19 score was the main outcome measure. Results The mean age of participants was 35.77 years (SD=8.07), with mean disease duration of 1.84 years (SD=0.79). Cronbach's alpha coefficient was 0.90 for total MSISQ-19 score, with values of 0.85, 0.90, and 0.78 for the subscales assessing primary, secondary, and tertiary sexual dysfunction, respectively. The principal component analysis indicated a three-factor solution, similar to that found in the original validation study, that explained 63.0% of the total variance for women with MS. Scores on the MSISQ-19 and its subscales correlated with scores on the FSFI, EDSS, and BDI-II (all P<0.01). Conclusion In general, the findings suggest that the MSISQ-19 is a reliable and valid measure of sexual function among Iranian women with MS. However, further studies are needed to establish psychometric properties for male MS patients in Iran. Mohammadi K, Rahnama P, Montazer A, and Foley FW. The Multiple Sclerosis Intimacy and Sexuality Questionnaire-19: Reliability, validity, and factor structure of the Persian version. J Sex Med 2014;11:2225-2231.
引用
收藏
页码:2225 / 2231
页数:7
相关论文
共 27 条
  • [1] Aschka C, 2001, J FAM PRACTICE, V50, P773
  • [2] Beck AT., 1996, Manual for the beck depression inventory-II
  • [3] Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention
    Bronner, G.
    Elran, E.
    Golomb, J.
    Korczyn, A. D.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2010, 121 (05): : 289 - 301
  • [4] Dobson K.S., 2007, J REHABIL, V8, P80
  • [5] A 20-Year Incidence Trend (1989-2008) and Point Prevalence (March 20, 2009) of Multiple Sclerosis in Tehran, Iran: A Population-Based Study
    Elhami, Seyedeh-Robab
    Mohammad, Kazem
    Sahraian, Mohammad Ali
    Eftekhar, Hassan
    [J]. NEUROEPIDEMIOLOGY, 2011, 36 (03) : 141 - 147
  • [6] Foley F.W., 1997, MS Management, V4, P1
  • [7] The Multiple Sclerosis Intimacy and Sexuality Questionnaire - re-validation and development of a 15-item version with a large US sample
    Foley, Frederick W.
    Zemon, Vance
    Campagnolo, Denise
    Marrie, Ruth Ann
    Cutter, Gary
    Tyry, Tuula
    Beier, Meghan
    Farrell, Eileen
    Vollmer, Timothy
    Schairer, Laura
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (09) : 1197 - 1203
  • [8] Foley FW, 2001, MULT SCLER J, V7, P417, DOI 10.1191/135245801701567005
  • [9] Foley FW, 2012, MULTIPLE SCLEROSIS Q, P147
  • [10] Glass C.A., 1995, J MENT HEALTH, V4, P251, DOI DOI 10.1080/09638239550037532